KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EPS (Weighted Average and Diluted) (2019 - 2025)

Exact Sciences (EXAS) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$0.45 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 90.36% to -$0.45 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 through Dec 2025, up 80.25% year-over-year, with the annual reading at -$1.1 for FY2025, 80.32% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.45 at Exact Sciences, down from -$0.1 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.0 in Q3 2023, with the low at -$4.67 in Q4 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.74, with a median of -$0.5 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 100.51% in 2023, then tumbled 4968.48% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$1.28 in 2021, then soared by 43.75% to -$0.72 in 2022, then skyrocketed by 62.5% to -$0.27 in 2023, then tumbled by 1629.63% to -$4.67 in 2024, then soared by 90.36% to -$0.45 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.45, -$0.1, and -$0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.